A.I. Virtanen Institute for Molecular Sciences - News

To the researchers' knowledge this is the first report for altered transmitophagy in Alzheimer’s disease.

The project seeks to combine three leading research groups’ different approaches to the development of novel and tailored immunotherapeutic treatments for glioblastoma.

Typically, proteins accumulating in the brain of patients with FTD and harming their neurons are either TDP-43 or tau proteins.

UEF Bioinformatics Center and THL Biobank announce a new service for genetic imputation using a Finnish haplotype reference panel.

The research presents a diagnostic biomarker that could be used to select animals likely to develop epilepsy after the experimental traumatic brain injury.

The doctoral dissertation focuses on the segmentation of magnetic resonance images with deep learning. The automatic segmentations were of higher quality than those produced with other methods, and more accurate than those annotated by an expert, which is important for reproducibility.

Bristol-Myers Squibb has granted 790,000 euros for the Cardiopath study led by Professors Johanna Kuusisto and Pasi Tavi.

For the first time, a combination of the diabetes medicine metformin and a lifestyle intervention is being tested in the prevention of memory disorders.

The Research Council’s funding to Academy Projects in natural sciences and engineering at UEF amounts to 2.68 million euros.

The launch of the clinical trials will be moved to 2023.